Oxymetazoline and Blepharoptosis: A Case Series and Proposed Treatment Algorithm. [PDF]
Brito EM +7 more
europepmc +1 more source
Six-month efficacy and safety of oxymetazoline hydrochloride 0.1% in Japanese patients with acquired blepharoptosis: a phase 3 study. [PDF]
Ishikawa H, Oka K, Inoue H.
europepmc +1 more source
sc-MULTI-omics approach in nano-rare diseases: understanding the pathophysiological mechanism of Mulvihill-Smith Syndrome. [PDF]
Riess A +7 more
europepmc +1 more source
Duane Retraction Syndrome: A Report of Two Cases and Review of Literature. [PDF]
Abu Melha A +4 more
europepmc +1 more source
Post-marketing safety evaluation of paroxetine: a real-world pharmacovigilance analysis based on the FDA adverse event reporting system. [PDF]
Chokkakula S +5 more
europepmc +1 more source
The p.Ile202Thr Substitution in TUBB2B Can Be Associated with Syndromic Presentation of Congenital Fibrosis of the Extraocular Muscles. [PDF]
Mancini C +17 more
europepmc +1 more source
Comparison of Conjoint Fascial Sheath Suspension and Levator Muscle-conjoint Fascial Sheath Complex Suspension in Blepharoptosis. [PDF]
Hou K +6 more
europepmc +1 more source
Corrugator Supercilii Muscle and Its Relationship with Neurovascular Structures of the Frontal Region: A Cadaveric Study. [PDF]
Yildiz N +4 more
europepmc +1 more source
Serum proteomic profiling of physical activity reveals CD300LG as a novel exerkine with a potential causal link to glucose homeostasis. [PDF]
Lee-Ødegård S +16 more
europepmc +1 more source

